JP2019507113A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019507113A5 JP2019507113A5 JP2018534626A JP2018534626A JP2019507113A5 JP 2019507113 A5 JP2019507113 A5 JP 2019507113A5 JP 2018534626 A JP2018534626 A JP 2018534626A JP 2018534626 A JP2018534626 A JP 2018534626A JP 2019507113 A5 JP2019507113 A5 JP 2019507113A5
- Authority
- JP
- Japan
- Prior art keywords
- biodegradable
- disease
- antigen
- subject
- particles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021105106A JP7333360B2 (ja) | 2016-01-04 | 2021-06-24 | 結合エピトープを含有する融合タンパク質を封入する粒子 |
| JP2023132166A JP7730867B2 (ja) | 2016-01-04 | 2023-08-14 | 結合エピトープを含有する融合タンパク質を封入する粒子 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662274711P | 2016-01-04 | 2016-01-04 | |
| US62/274,711 | 2016-01-04 | ||
| PCT/US2017/012173 WO2017120222A1 (en) | 2016-01-04 | 2017-01-04 | Particles encapsulating fusion proteins containing linked epitopes |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021105106A Division JP7333360B2 (ja) | 2016-01-04 | 2021-06-24 | 結合エピトープを含有する融合タンパク質を封入する粒子 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019507113A JP2019507113A (ja) | 2019-03-14 |
| JP2019507113A5 true JP2019507113A5 (enExample) | 2020-02-06 |
| JP6904959B2 JP6904959B2 (ja) | 2021-07-21 |
Family
ID=59274014
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018534626A Active JP6904959B2 (ja) | 2016-01-04 | 2017-01-04 | 結合エピトープを含有する融合タンパク質を封入する粒子 |
| JP2021105106A Active JP7333360B2 (ja) | 2016-01-04 | 2021-06-24 | 結合エピトープを含有する融合タンパク質を封入する粒子 |
| JP2023132166A Active JP7730867B2 (ja) | 2016-01-04 | 2023-08-14 | 結合エピトープを含有する融合タンパク質を封入する粒子 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021105106A Active JP7333360B2 (ja) | 2016-01-04 | 2021-06-24 | 結合エピトープを含有する融合タンパク質を封入する粒子 |
| JP2023132166A Active JP7730867B2 (ja) | 2016-01-04 | 2023-08-14 | 結合エピトープを含有する融合タンパク質を封入する粒子 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20190365656A1 (enExample) |
| EP (1) | EP3400069A4 (enExample) |
| JP (3) | JP6904959B2 (enExample) |
| CA (1) | CA3009799A1 (enExample) |
| IL (2) | IL260296B2 (enExample) |
| WO (1) | WO2017120222A1 (enExample) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9597385B2 (en) | 2012-04-23 | 2017-03-21 | Allertein Therapeutics, Llc | Nanoparticles for treatment of allergy |
| EP3760223A1 (en) | 2013-04-03 | 2021-01-06 | N-Fold Llc | Nanoparticle composition for desensitizing a subject to peanut allergens |
| EP3247384B1 (en) * | 2015-01-14 | 2023-10-04 | The Regents of the University of Colorado, a body corporate | In vitro method of diagnosis of type 1 diabetes with insulin mimotopes |
| GB201508025D0 (en) | 2015-05-11 | 2015-06-24 | Ucl Business Plc | Fabry disease gene therapy |
| CN109475628A (zh) | 2016-05-18 | 2019-03-15 | 库尔生物制药有限公司 | T细胞调节性多聚体多肽及其使用方法 |
| AU2017379900B2 (en) | 2016-12-22 | 2024-12-05 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides and methods of use thereof |
| WO2018129474A1 (en) | 2017-01-09 | 2018-07-12 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides and methods of use thereof |
| EP3596118B1 (en) | 2017-03-15 | 2024-08-21 | Cue Biopharma, Inc. | Combination of multimeric fusion polypeptides and immune checkpoint inhibitor for treating hpv-associated cancer |
| KR102661060B1 (ko) * | 2017-07-06 | 2024-04-25 | 니토 보세키 가부시기가이샤 | 항인간 IgG4 모노클로날 항체, 및 그 항체를 이용한 인간 IgG4 측정 시약 |
| JP2021500855A (ja) * | 2017-09-07 | 2021-01-14 | キュー バイオファーマ， インコーポレイテッド | 抗原提示ポリペプチドおよびその使用方法 |
| WO2019131769A1 (ja) * | 2017-12-26 | 2019-07-04 | 公立大学法人名古屋市立大学 | 新規抗ｐａｄ４抗体 |
| WO2019139896A1 (en) | 2018-01-09 | 2019-07-18 | Cue Biopharma, Inc. | Multimeric t-cell modulatory polypeptides and methods of use thereof |
| CN110041408B (zh) * | 2018-01-16 | 2021-05-18 | 华中科技大学 | 一种小分子多肽及其在制备防治帕金森综合症药物中的应用 |
| MX2020013155A (es) | 2018-06-05 | 2021-04-29 | Anji Pharma Us Llc | Composiciones y metodos para tratar la pancreatitis. |
| MA52870A (fr) * | 2018-06-13 | 2021-04-21 | Acraf | Peptides ayant une activité inhibitrice sur le récepteur muscarinique m3 |
| AU2020316005A1 (en) * | 2019-07-19 | 2022-02-24 | The Regents Of The University Of Michigan | Compositions and methods for treating autoimmune disorders |
| US20230302083A1 (en) * | 2020-04-20 | 2023-09-28 | The General Hospital Corporation | Highly-networked coronavirus immunogen composition |
| EP4149534A4 (en) | 2020-05-12 | 2024-09-04 | Cue Biopharma, Inc. | MULTIMERIC POLYPEPTIDES MODULATING T CELLS AND METHODS OF USE THEREOF |
| IT202000010888A1 (it) * | 2020-05-13 | 2021-11-13 | Consiglio Nazionale Ricerche | Nanovescicole di mielina e loro impieghi |
| WO2022056014A1 (en) | 2020-09-09 | 2022-03-17 | Cue Biopharma, Inc. | Mhc class ii t-cell modulatory multimeric polypeptides for treating type 1 diabetes mellitus (t1d) and methods of use thereof |
| GB202017119D0 (en) * | 2020-10-28 | 2020-12-09 | Oxford Vacmedix Uk Ltd | Polypeptides for cancer treatment |
| JP2024518277A (ja) | 2021-04-16 | 2024-05-01 | クール ファーマシューティカルズ ディベロップメント カンパニー インコーポレイテッド | 免疫寛容の維持を追跡する方法 |
| CN117957017A (zh) * | 2021-05-11 | 2024-04-30 | 牛津疫苗医学公司 | 包含重组重叠肽和天然蛋白质的疫苗制剂 |
| US20250084126A1 (en) * | 2021-07-07 | 2025-03-13 | Osaka University | Peptide and composition |
| MX2024004851A (es) | 2021-10-21 | 2024-06-12 | Cour Pharmaceuticals Dev Company Inc | Tratamiento de cirrosis biliar primaria (pbc) con nanoparticulas tolerizantes. |
| EP4436557A4 (en) * | 2021-11-24 | 2025-06-11 | Cour Pharmaceuticals Development Company Inc. | PRODUCTION OF TOLERANT NANOPARTICLES FOR THE TREATMENT OF PEANUT ALLERGY |
| WO2023180547A1 (en) * | 2022-03-24 | 2023-09-28 | Julius-Maximilians-Universität Würzburg | Mhc ib-mediated islet-antigen-specific immunosuppression as a novel treatment for type 1 diabetes |
| CN119173251A (zh) | 2022-04-29 | 2024-12-20 | 库尔制药开发公司 | 用于克服治疗性载体和蛋白质的免疫原性的耐受性免疫修饰纳米粒子 |
| CN115541872A (zh) * | 2022-09-22 | 2022-12-30 | 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） | 一种pd-l1检测试剂盒及其检测方法 |
| CN120282796A (zh) | 2022-10-19 | 2025-07-08 | 库尔制药开发公司 | 用耐受性纳米颗粒治疗花生过敏 |
| CN115771883B (zh) * | 2022-11-28 | 2024-02-23 | 淮阴工学院 | 从酿酒酵母发酵液中提取的蛋白酶a在化学法合成纳米硒形貌控制和稳定性影响中的用途 |
| KR20250162851A (ko) | 2023-03-24 | 2025-11-19 | 코어 파마슈티칼스 디벨롭먼트 컴퍼니 인크. | 중증 근무력증 치료를 위한 관용화 면역 변형 나노입자 |
| WO2024243410A1 (en) | 2023-05-23 | 2024-11-28 | Cour Pharmaceuticals Development Company Inc. | Preparation of tolerizing nanoparticles for the treatment of primary biliary cholangitis |
| TW202500576A (zh) | 2023-05-25 | 2025-01-01 | 美商庫爾製藥發展公司股份有限公司 | 以免疫耐受性(tolerizing)奈米粒子治療1型糖尿病(t1d) |
| WO2025027015A1 (en) * | 2023-08-01 | 2025-02-06 | Diamante Srl | Composition and methods for treating multiple sclerosis |
| WO2025043196A2 (en) * | 2023-08-24 | 2025-02-27 | The Trustees Of Indiana University | Anti-cancer peptides, and methods and uses thereof |
| WO2025199149A1 (en) | 2024-03-18 | 2025-09-25 | Cour Pharmaceuticals Development Company Inc. | Sting agonism for antigen specific tolerance |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2352738A1 (en) * | 1998-12-04 | 2000-06-08 | Biogen, Inc. | Hbv core antigen particles with multiple immunogenic components attached via peptide ligands |
| WO2001094944A2 (en) * | 2000-06-02 | 2001-12-13 | Memorial Sloan-Kettering Cancer Center | Artificial antigen presenting cells and methods of use thereof |
| US20060222656A1 (en) * | 2005-04-01 | 2006-10-05 | University Of Maryland, Baltimore | MAGE-A3/HPV 16 peptide vaccines for head and neck cancer |
| EP2185195A2 (en) * | 2007-08-16 | 2010-05-19 | Tripep Ab | Immunogen platform |
| JP6200806B2 (ja) * | 2010-05-21 | 2017-09-20 | メリマック ファーマシューティカルズ インコーポレーティッド | 二重特異的融合タンパク質 |
| BR112013004288A2 (pt) * | 2010-08-23 | 2016-05-31 | Selecta Biosciences Inc | formas galênicas de múltiplos epítopos direcionados para indução de uma resposta imunológica a antigênios. |
| AU2013221187B9 (en) * | 2012-02-16 | 2018-01-04 | Vlp Therapeutics, Inc. | Virus like particle composition |
| KR20250052503A (ko) * | 2012-06-21 | 2025-04-18 | 노쓰웨스턴유니버시티 | 펩티드 접합된 입자 |
| JP6553033B2 (ja) * | 2013-08-13 | 2019-07-31 | ノースウェスタン ユニバーシティ | ペプチドコンジュゲート粒子 |
| JP2019504895A (ja) * | 2016-02-09 | 2019-02-21 | クール ファーマシューティカルズ ディベロップメント カンパニー インコーポレイテッド | スギ花粉エピトープを封入するｔｉｍｐ（組織性メタロプロテアーゼ阻害因子） |
-
2017
- 2017-01-04 US US16/067,867 patent/US20190365656A1/en not_active Abandoned
- 2017-01-04 WO PCT/US2017/012173 patent/WO2017120222A1/en not_active Ceased
- 2017-01-04 EP EP17736249.8A patent/EP3400069A4/en active Pending
- 2017-01-04 IL IL260296A patent/IL260296B2/en unknown
- 2017-01-04 JP JP2018534626A patent/JP6904959B2/ja active Active
- 2017-01-04 CA CA3009799A patent/CA3009799A1/en active Pending
-
2021
- 2021-06-24 JP JP2021105106A patent/JP7333360B2/ja active Active
-
2023
- 2023-06-12 US US18/333,103 patent/US20240122864A1/en active Pending
- 2023-07-19 IL IL304580A patent/IL304580A/en unknown
- 2023-08-14 JP JP2023132166A patent/JP7730867B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019507113A5 (enExample) | ||
| JP2017532952A5 (enExample) | ||
| JP2019511222A5 (enExample) | ||
| HRP20241228T1 (hr) | T stanični receptori i imunološka terapija uporabom istih protiv pram pozitivnih karcinoma | |
| JP2010516290A5 (enExample) | ||
| JP2013181034A5 (enExample) | ||
| JP2019507135A5 (enExample) | ||
| JP2011521662A5 (enExample) | ||
| JP2016519932A5 (enExample) | ||
| HRP20150799T1 (hr) | Sastavi i postupci za protutijela protiv komplementnog proteina c5 | |
| JP2017531642A5 (enExample) | ||
| JP2012518425A5 (enExample) | ||
| JP2017507936A5 (enExample) | ||
| JP2015143226A5 (enExample) | ||
| JP2017531427A5 (enExample) | ||
| JP2018533966A5 (enExample) | ||
| JP7656627B2 (ja) | 変異表面糖タンパク質担体のための免疫化スキーム | |
| JP2016504993A5 (enExample) | ||
| JP2017504321A5 (enExample) | ||
| JPWO2020059847A5 (enExample) | ||
| RU2017124141A (ru) | Растворимый универсальный усиливающий adcc синтетический слитный ген, пептидная технология и их применение | |
| EP3368569A1 (en) | Polypeptides against il-23 | |
| JP2016508143A5 (enExample) | ||
| CN112513088A (zh) | 抗ox40抗体、其抗原结合片段及其医药用途 | |
| JP2018502068A5 (enExample) |